Mikel Lipschitz

2.4k total citations · 1 hit paper
14 papers, 1.0k citations indexed

About

Mikel Lipschitz is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Mikel Lipschitz has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Immunology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Mikel Lipschitz's work include Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (5 papers) and Immunotherapy and Immune Responses (5 papers). Mikel Lipschitz is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (5 papers) and Immunotherapy and Immune Responses (5 papers). Mikel Lipschitz collaborates with scholars based in United States, Netherlands and United Kingdom. Mikel Lipschitz's co-authors include Scott J. Rodig, Gordon J. Freeman, Evisa Gjini, Margaret A. Shipp, F. Stephen Hodi, Ali Amin‐Mansour, Diana Miao, Peter S. Hammerman, Kwok‐Kin Wong and Sachet A. Shukla and has published in prestigious journals such as Blood, Immunity and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Mikel Lipschitz

14 papers receiving 1.0k citations

Hit Papers

Loss of PTEN Is Associated with Resistance to Anti-PD-1 C... 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
    2017 361 citations Suzanne George, Diana Miao et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikel Lipschitz United States 10 786 536 330 220 168 14 1.0k
Yue Lu China 20 683 0.9× 436 0.8× 432 1.3× 278 1.3× 110 0.7× 51 1.2k
Christoph Mancao United States 15 867 1.1× 312 0.6× 396 1.2× 165 0.8× 221 1.3× 42 1.2k
Erik Yusko United States 16 984 1.3× 710 1.3× 158 0.5× 167 0.8× 242 1.4× 30 1.4k
Genevive Hernandez United States 12 624 0.8× 193 0.4× 241 0.7× 180 0.8× 121 0.7× 26 752
Han Myint United States 14 456 0.6× 453 0.8× 184 0.6× 321 1.5× 193 1.1× 30 1.1k
Federico Sandoval France 9 777 1.0× 594 1.1× 114 0.3× 306 1.4× 179 1.1× 16 1.1k
Margaretha G.M. Roemer Netherlands 10 689 0.9× 380 0.7× 557 1.7× 107 0.5× 86 0.5× 18 963
Harm Westdorp Netherlands 14 439 0.6× 255 0.5× 85 0.3× 175 0.8× 140 0.8× 43 696
Alison Klein United States 3 1.7k 2.1× 843 1.6× 176 0.5× 202 0.9× 463 2.8× 4 1.9k

Countries citing papers authored by Mikel Lipschitz

Since Specialization
Citations

This map shows the geographic impact of Mikel Lipschitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikel Lipschitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikel Lipschitz more than expected).

Fields of papers citing papers by Mikel Lipschitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikel Lipschitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikel Lipschitz. The network helps show where Mikel Lipschitz may publish in the future.

Co-authorship network of co-authors of Mikel Lipschitz

This figure shows the co-authorship network connecting the top 25 collaborators of Mikel Lipschitz. A scholar is included among the top collaborators of Mikel Lipschitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikel Lipschitz. Mikel Lipschitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Boucher, Yves, Ashwin S. Kumar, Jessica M. Posada, et al.. (2021). Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients. npj Precision Oncology. 5(1). 62–62. 30 indexed citations
2.
Patel, Sanjay S., Mikel Lipschitz, Geraldine S. Pinkus, et al.. (2020). Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironment. Modern Pathology. 33(7). 1380–1388. 8 indexed citations
3.
Chen, Pei-Hsuan, Mikel Lipschitz, Jason L. Weirather, et al.. (2020). Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapy. JCI Insight. 5(12). 59 indexed citations
4.
5.
Patel, Sanjay S., Jason L. Weirather, Mikel Lipschitz, et al.. (2019). The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4- positive T-cells that are PD-1-negative. Blood. 134(23). 2059–2069. 82 indexed citations
6.
7.
Cader, Fathima Zumla, Ron C.J. Schackmann, Xihao Hu, et al.. (2018). Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell–rich and exhausted T-effector microenvironment. Blood. 132(8). 825–836. 111 indexed citations
8.
Schoenfeld, Jonathan D., Evisa Gjini, Scott J. Rodig, et al.. (2018). Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 102(1). 137–145. 23 indexed citations
9.
Griffin, Gabriel K., Margaretha G.M. Roemer, Mikel Lipschitz, et al.. (2018). Integrated Genetic and Topological Analysis Reveals a Hodgkin-like Mechanism of Immune Escape in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma. Blood. 132(Supplement 1). 1579–1579. 2 indexed citations
10.
Chen, Pei-Hsuan, Mikel Lipschitz, Kyle Wright, et al.. (2018). Analysis of CAR-T and Immune Cells within the Tumor Micro-Environment of Diffuse Large B-Cell Lymphoma Post CAR-T Treatment By Multiplex Immunofluorescence. Blood. 132(Supplement 1). 678–678. 4 indexed citations
11.
12.
George, Suzanne, Diana Miao, George D. Demetri, et al.. (2017). Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma. Immunity. 46(2). 197–204. 361 indexed citations breakdown →
13.
Carey, Christopher D., Daniel Gusenleitner, Mikel Lipschitz, et al.. (2017). Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma. Blood. 130(22). 2420–2430. 219 indexed citations
14.
Wu, Xinqi, Anita Giobbie‐Hurder, Xiaoyun Liao, et al.. (2016). Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy. Cancer Immunology Research. 5(1). 17–28. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yue Lu Breakdown of academic impact, for papers by Christoph Mancao Breakdown of academic impact, for papers by Erik Yusko Breakdown of academic impact, for papers by Genevive Hernandez Breakdown of academic impact, for papers by Han Myint Breakdown of academic impact, for papers by Federico Sandoval Breakdown of academic impact, for papers by Margaretha G.M. Roemer Breakdown of academic impact, for papers by Harm Westdorp Breakdown of academic impact, for papers by Alison Klein
Rankless by CCL
2026